Intubation with Blockbuster LMA in obese patients compared with Fastrach LMA

Comparison of blockbuster LMA versus fastrach LMA as a conduit for blind orotracheal intubation in obese patients - LMA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075457

Enrollment

Registered

2024-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Blind orotracheal intubation with intubating LMA in obese patients: Blind orotracheal intubation with blockbuster LMA in obese patients Control Intervention1: Blind orotracheal intubati

Eligibility

Inclusion criteria

Inclusion criteria: Elective surgeries under general anaesthesia BMI: 25-40 kg/m2 ASA grade 1 and 2 Patients of either sex

Exclusion criteria

Exclusion criteria: Any oropharyngeal pathology

Design outcomes

Primary

Measure	Time frame
total number of attempts for successful intubation with either of the advice.Timepoint: Time from the insertion of LMA to confirmation of endotracheal tube by waveform capnography.	—

Secondary

Measure	Time frame
1. time for LMA insertion 2. time for endotracheal tube insertion 3. post op complications with use of SADTimepoint: 1. time for LMA insertion will be measured from removal of face mask till adequate ventilation established through LMA. 2. time for endotracheal intubation measured from disconnecting the LMA from breathing circuit till adequate ventilation established through endotracheal tube. 3. post op complications with use of SAD such a as sore throat, blood staining of device.	—

Measure

Time frame

1. time for LMA insertion 2. time for endotracheal tube insertion 3. post op complications with use of SADTimepoint: 1. time for LMA insertion will be measured from removal of face mask till adequate ventilation established through LMA. 2. time for endotracheal intubation measured from disconnecting the LMA from breathing circuit till adequate ventilation established through endotracheal tube. 3. post op complications with use of SAD such a as sore throat, blood staining of device.

—

Countries

India

Contacts

Public ContactDr Bhawna Garg

Employees State insurance Corporation Postgraduate Institute Of Medical Science and Research

Dr_vkmohan@yahoo.com9891557705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026